Ivan Mesquita - Sanofi
Por um escritor misterioso
Descrição
IT SAP multiproduct Manager experienced delivering major projects in complex… | Obtén más información sobre la experiencia laboral, la educación, los contactos y otra información sobre Ivan Mesquita visitando su perfil en LinkedIn
![Ivan Mesquita - Sanofi](https://i1.rgstatic.net/publication/371541256_State-of-the-Art_in_the_Drug_Discovery_Pathway_for_Chagas_Disease_A_Framework_for_Drug_Development_and_Target_Validation/links/6489afab9605ba270e44ad94/largepreview.png)
PDF) State-of-the-Art in the Drug Discovery Pathway for Chagas
![Ivan Mesquita - Sanofi](https://www.frontiersin.org/files/Articles/1204483/fcvm-10-1204483-HTML-r1/image_m/fcvm-10-1204483-g001.jpg)
Frontiers Mitochondrial epigenetics in aging and cardiovascular
![Ivan Mesquita - Sanofi](https://www.jacc.org/cms/asset/71350af0-e2f6-44da-9ab1-c85f69695c73/gr4.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With
![Ivan Mesquita - Sanofi](https://i1.rgstatic.net/publication/342854071_Glanzmann's_Thrombasthenia_How_Listening_to_the_Patient_Is_Sometimes_the_Simple_Key_to_Good_Medicine/links/5f093552a6fdcc4ca45e1da6/largepreview.png)
PDF) Glanzmann's Thrombasthenia: How Listening to the Patient Is
![Ivan Mesquita - Sanofi](https://www.jacc.org/cms/asset/cd8c5efb-f63c-42a5-b263-4e6902e1b8c6/gr2b.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With
![Ivan Mesquita - Sanofi](https://onlinelibrary.wiley.com/cms/asset/32d1237d-291d-410c-bcb5-3a0773026879/all14506-fig-0009-m.jpg)
Abstract - 2020 - Allergy - Wiley Online Library
![Ivan Mesquita - Sanofi](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-021-01342-6/MediaObjects/41409_2021_1342_Figr_HTML.png)
The 47th Annual Meeting of the European Society for Blood and
![Ivan Mesquita - Sanofi](https://www.e-dmj.org/upload/thumbnails/dmj-2020-0291f4.jpg)
Diabetes & Metabolism Journal
![Ivan Mesquita - Sanofi](https://i0.wp.com/media.bizj.us/view/img/12454773/j-harris-headshot-pidc-jpeg*750xx2048-1154-0-89.jpg?w=500&ssl=1)
BioTechnology – Venture Creation, Venture Capital
![Ivan Mesquita - Sanofi](https://www.frontiersin.org/files/Articles/909896/fimmu-13-909896-HTML-r1/image_m/fimmu-13-909896-g004.jpg)
Frontiers Type-2 Cytokines Promote the Secretion of the
![Ivan Mesquita - Sanofi](https://www.jacc.org/cms/asset/6e8bade0-0426-4eec-a434-aa6063cacfbe/gr3.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With
![Ivan Mesquita - Sanofi](https://wolterskluwerblogs.com/patent/wp-content/uploads/sites/52/2023/02/1122-KIPL-FRL-1x191-003.jpg)
The UPC – a tale of multiple divisions - Kluwer Patent Blog
![Ivan Mesquita - Sanofi](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2021/03/oldgenzyme.jpeg?resize=480%2C320&ssl=1)
BioTechnology – Venture Creation, Venture Capital
30+ Ivan Mesquita profiles
de
por adulto (o preço varia de acordo com o tamanho do grupo)